Fundz
Real-time · AI · Cross-signal

Discover the power of real-time signals plus AI

Every funding round, exec hire, M&A move, contract, and sentiment shift on Tcr Cure — with verified, ICP-scored contact reveals (email + mobile) on demand.

Trusted by founders, sales teams, recruiters, and investors at firms like BlackRock, Oracle, Kleiner Perkins, and HubSpot.

See plansBook a 15-min walkthrough
▶
Watch the 2-minute tour · with sound

Tcrcure Nets Over $47M In Funding

PRIVATEFeb 16, 2022•about 4 years ago

Amount Raised

$47 Million

Description

Next-generation cancer immunotherapies developer TCRCure Biopharma has received over 300 million yuan ($47 million) in a new round of funding.

Company Information

Company

Tcr Cure

About

With headcount spanning over150 professionals, TCRCure develops novel cancer immunotherapies that benefit patients who suffer from tumour progression, and chronic diseases, among others. TCRCure, which currently operates in Los Angeles, North Carolina, Chongqing and Guangzhou, claims to launch an initial public offering (IPO) in 2023.

Predictive Intelligence
Strategic

ML-powered predictions for Tcr Cure's next move

Learn about Strategic plan

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, FundzIQ™ for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies.

Watching Tcr Cure? See every signal — funding, hires, M&A, contracts, sentiment.

See plans